XML 52 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies - Additional Information (Detail) - USD ($)
$ in Thousands
9 Months Ended 232 Months Ended
May 31, 2005
Sep. 30, 2024
Sep. 30, 2024
Dec. 31, 2023
Purchase Commitment        
Purchase Commitment, Excluding Long-Term Commitment [Line Items]        
Cash paid   $ 30,100 $ 30,100 $ 15,100
Other current assets   24,000 24,000 7,900
Other assets   6,100 6,100 $ 7,200
Product | Bristol-Myers Squibb Company        
Purchase Commitment, Excluding Long-Term Commitment [Line Items]        
Company made an upfront payment     10,800  
Payment of milestone amount   $ 5,000 $ 5,000  
Obliged to make milestone payments $ 14,750      
License expiration period   10 years    
Product | Bristol-Myers Squibb Company | Minimum        
Purchase Commitment, Excluding Long-Term Commitment [Line Items]        
Royalty payment, percentage (as a percent) 5.00%      
Product | Bristol-Myers Squibb Company | Maximum        
Purchase Commitment, Excluding Long-Term Commitment [Line Items]        
Royalty payment, percentage (as a percent) 9.00%